APO Research
Talk to an analyst

APO RESEARCH · REPORT

Needle-free Hypodermic Syringe

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Needle-free Hypodermic Syringe Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025190 pages

Choose your research edition.

Industry ResearchNeedle-free Hypodermic Syringe Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Needle-free Hypodermic Syringe Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Needle-free Hypodermic Syringe Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Needle-free Hypodermic Syringe Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Needle-free Hypodermic Syringe Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Needle-free Hypodermic Syringe market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Needle-free Hypodermic Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Needle-free Hypodermic Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Needle-free Hypodermic Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Needle-free Hypodermic Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Needle-free Hypodermic Syringe include Zoetis, Aptar Pharma, Veloxis Pharmaceuticals, SHL Medical, Portal Instruments, PharmaJet, PenJet, Oval Medical Technologies and Lifecare AS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Needle-free Hypodermic Syringe market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Needle-free Hypodermic Syringe and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Needle-free Hypodermic Syringe sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Needle-free Hypodermic Syringe market size, projected growth trends, production technologies, key applications, and end-use industries.

Needle-free Hypodermic Syringe Segment by Company

Zoetis

Aptar Pharma

Veloxis Pharmaceuticals

SHL Medical

Portal Instruments

PharmaJet

PenJet

Oval Medical Technologies

Lifecare AS

Enable Injections

Crossject

Antares Pharma

Needle-free Hypodermic Syringe Segment by Type

Electric Needle-Free Injector

Hydraulic Needle-Free Injector

Needle-free Hypodermic Syringe Segment by Application

Hospital

Specialist Clinic

Others

Needle-free Hypodermic Syringe Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Needle-free Hypodermic Syringe market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Needle-free Hypodermic Syringe and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Needle-free Hypodermic Syringe.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Needle-free Hypodermic Syringe market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Needle-free Hypodermic Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Needle-free Hypodermic Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Needle-free Hypodermic Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Needle-free Hypodermic Syringe Industry Trends Table 2. Needle-free Hypodermic Syringe Industry Drivers Table 3. Needle-free Hypodermic Syringe Industry Opportunities and Challenges Table 4. Needle-free Hypodermic Syringe Industry Restraints Table 5. Global Needle-free Hypodermic Syringe Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Needle-free Hypodermic Syringe Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Needle-free Hypodermic Syringe Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Needle-free Hypodermic Syringe Sales Market Share by Manufacturers Table 9. Global Needle-free Hypodermic Syringe Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Needle-free Hypodermic Syringe Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Needle-free Hypodermic Syringe Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Needle-free Hypodermic Syringe Manufacturers, Product Type & Application Table 13. Global Needle-free Hypodermic Syringe Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Needle-free Hypodermic Syringe by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Electric Needle-Free Injector Table 17. Major Manufacturers of Hydraulic Needle-Free Injector Table 18. Global Needle-free Hypodermic Syringe Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Needle-free Hypodermic Syringe Sales by Type (2021-2026) & (K Units) Table 20. Global Needle-free Hypodermic Syringe Sales by Type (2027-2032) & (K Units) Table 21. Global Needle-free Hypodermic Syringe Sales Market Share by Type (2021-2026) Table 22. Global Needle-free Hypodermic Syringe Sales Market Share by Type (2027-2032) Table 23. Global Needle-free Hypodermic Syringe Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Needle-free Hypodermic Syringe Revenue by Type (2021-2026) & (K Units) Table 25. Global Needle-free Hypodermic Syringe Revenue by Type (2027-2032) & (K Units) Table 26. Global Needle-free Hypodermic Syringe Revenue Market Share by Type (2021-2026) Table 27. Global Needle-free Hypodermic Syringe Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Specialist Clinic Table 30. Major Manufacturers of Others Table 31. Global Needle-free Hypodermic Syringe Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Needle-free Hypodermic Syringe Sales by Application (2021-2026) & (K Units) Table 33. Global Needle-free Hypodermic Syringe Sales by Application (2027-2032) & (K Units) Table 34. Global Needle-free Hypodermic Syringe Sales Market Share by Application (2021-2026) Table 35. Global Needle-free Hypodermic Syringe Sales Market Share by Application (2027-2032) Table 36. Global Needle-free Hypodermic Syringe Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Needle-free Hypodermic Syringe Revenue by Application (2021-2026) & (K Units) Table 38. Global Needle-free Hypodermic Syringe Revenue by Application (2027-2032) & (K Units) Table 39. Global Needle-free Hypodermic Syringe Revenue Market Share by Application (2021-2026) Table 40. Global Needle-free Hypodermic Syringe Revenue Market Share by Application (2027-2032) Table 41. Global Needle-free Hypodermic Syringe Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Needle-free Hypodermic Syringe Sales by Region (2021-2026) & (K Units) Table 43. Global Needle-free Hypodermic Syringe Sales Market Share by Region (2021-2026) Table 44. Global Needle-free Hypodermic Syringe Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Needle-free Hypodermic Syringe Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Needle-free Hypodermic Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Needle-free Hypodermic Syringe Sales by Country (2021-2026) & (K Units) Table 48. North America Needle-free Hypodermic Syringe Sales by Country (2027-2032) & (K Units) Table 49. Europe Needle-free Hypodermic Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Needle-free Hypodermic Syringe Sales by Country (2021-2026) & (K Units) Table 51. Europe Needle-free Hypodermic Syringe Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Needle-free Hypodermic Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Needle-free Hypodermic Syringe Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Needle-free Hypodermic Syringe Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Needle-free Hypodermic Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Needle-free Hypodermic Syringe Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Needle-free Hypodermic Syringe Sales by Country (2027-2032) & (K Units) Table 58. Global Needle-free Hypodermic Syringe Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Needle-free Hypodermic Syringe Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Needle-free Hypodermic Syringe Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Needle-free Hypodermic Syringe Revenue Market Share by Region (2021-2026) Table 62. Global Needle-free Hypodermic Syringe Revenue Market Share by Region (2027-2032) Table 63. Zoetis Company Information Table 64. Zoetis Business Overview Table 65. Zoetis Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zoetis Needle-free Hypodermic Syringe Product Portfolio Table 67. Zoetis Recent Development Table 68. Aptar Pharma Company Information Table 69. Aptar Pharma Business Overview Table 70. Aptar Pharma Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Aptar Pharma Needle-free Hypodermic Syringe Product Portfolio Table 72. Aptar Pharma Recent Development Table 73. Veloxis Pharmaceuticals Company Information Table 74. Veloxis Pharmaceuticals Business Overview Table 75. Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Product Portfolio Table 77. Veloxis Pharmaceuticals Recent Development Table 78. SHL Medical Company Information Table 79. SHL Medical Business Overview Table 80. SHL Medical Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. SHL Medical Needle-free Hypodermic Syringe Product Portfolio Table 82. SHL Medical Recent Development Table 83. Portal Instruments Company Information Table 84. Portal Instruments Business Overview Table 85. Portal Instruments Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Portal Instruments Needle-free Hypodermic Syringe Product Portfolio Table 87. Portal Instruments Recent Development Table 88. PharmaJet Company Information Table 89. PharmaJet Business Overview Table 90. PharmaJet Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. PharmaJet Needle-free Hypodermic Syringe Product Portfolio Table 92. PharmaJet Recent Development Table 93. PenJet Company Information Table 94. PenJet Business Overview Table 95. PenJet Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. PenJet Needle-free Hypodermic Syringe Product Portfolio Table 97. PenJet Recent Development Table 98. Oval Medical Technologies Company Information Table 99. Oval Medical Technologies Business Overview Table 100. Oval Medical Technologies Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Oval Medical Technologies Needle-free Hypodermic Syringe Product Portfolio Table 102. Oval Medical Technologies Recent Development Table 103. Lifecare AS Company Information Table 104. Lifecare AS Business Overview Table 105. Lifecare AS Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Lifecare AS Needle-free Hypodermic Syringe Product Portfolio Table 107. Lifecare AS Recent Development Table 108. Enable Injections Company Information Table 109. Enable Injections Business Overview Table 110. Enable Injections Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Enable Injections Needle-free Hypodermic Syringe Product Portfolio Table 112. Enable Injections Recent Development Table 113. Crossject Company Information Table 114. Crossject Business Overview Table 115. Crossject Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Crossject Needle-free Hypodermic Syringe Product Portfolio Table 117. Crossject Recent Development Table 118. Antares Pharma Company Information Table 119. Antares Pharma Business Overview Table 120. Antares Pharma Needle-free Hypodermic Syringe Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Antares Pharma Needle-free Hypodermic Syringe Product Portfolio Table 122. Antares Pharma Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Needle-free Hypodermic Syringe Distributors List Table 126. Needle-free Hypodermic Syringe Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Needle-free Hypodermic Syringe Product Image Figure 2. Global Needle-free Hypodermic Syringe Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Needle-free Hypodermic Syringe Market Size (2021-2032) & (US$ Million) Figure 4. Global Needle-free Hypodermic Syringe Sales (2021-2032) & (K Units) Figure 5. Global Needle-free Hypodermic Syringe Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Needle-free Hypodermic Syringe Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Electric Needle-Free Injector Image Figure 9. Hydraulic Needle-Free Injector Image Figure 10. Global Needle-free Hypodermic Syringe Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Needle-free Hypodermic Syringe Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Needle-free Hypodermic Syringe Sales Market Share by Type (2021-2032) Figure 13. Global Needle-free Hypodermic Syringe Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Needle-free Hypodermic Syringe Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Needle-free Hypodermic Syringe Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Specialist Clinic Image Figure 18. Others Image Figure 19. Global Needle-free Hypodermic Syringe Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Needle-free Hypodermic Syringe Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Needle-free Hypodermic Syringe Sales Market Share by Application (2021-2032) Figure 22. Global Needle-free Hypodermic Syringe Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Needle-free Hypodermic Syringe Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Needle-free Hypodermic Syringe Revenue Market Share by Application (2021-2032) Figure 25. North America Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Needle-free Hypodermic Syringe Sales Market Share by Country (2021-2032) Figure 27. U.S. Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Needle-free Hypodermic Syringe Sales Market Share by Country (2021-2032) Figure 32. Germany Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Needle-free Hypodermic Syringe Sales Market Share by Country (2021-2032) Figure 39. China Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Needle-free Hypodermic Syringe Sales Market Share by Country (2021-2032) Figure 47. Brazil Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Needle-free Hypodermic Syringe Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Needle-free Hypodermic Syringe Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Needle-free Hypodermic Syringe Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Needle-free Hypodermic Syringe Revenue (2021-2032) & (US$ Million) Figure 58. North America Needle-free Hypodermic Syringe Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Needle-free Hypodermic Syringe Revenue (2021-2032) & (US$ Million) Figure 60. Europe Needle-free Hypodermic Syringe Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Needle-free Hypodermic Syringe Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Needle-free Hypodermic Syringe Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Needle-free Hypodermic Syringe Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Needle-free Hypodermic Syringe Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Needle-free Hypodermic Syringe Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Needle-free Hypodermic Syringe Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Electric Needle-Free Injector
  • Hydraulic Needle-Free Injector
Applications
  • Hospital
  • Specialist Clinic
  • Others
Companies covered
  • Zoetis
  • Aptar Pharma
  • Veloxis Pharmaceuticals
  • SHL Medical
  • Portal Instruments
  • PharmaJet
  • PenJet
  • Oval Medical Technologies
  • Lifecare AS
  • Enable Injections
  • Crossject
  • Antares Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Needle-free Hypodermic Syringe Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Needle-free Hypodermic Syringe Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Needle-free Hypodermic Syringe Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Needle-free Hypodermic Syringe Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Needle-free Hypodermic Syringe Market Dynamics
  1. 2.1 Needle-free Hypodermic Syringe Industry Trends
  2. 2.2 Needle-free Hypodermic Syringe Industry Drivers
  3. 2.3 Needle-free Hypodermic Syringe Industry Opportunities and Challenges
  4. 2.4 Needle-free Hypodermic Syringe Industry Restraints
3 Needle-free Hypodermic Syringe Market by Manufacturers
  1. 3.1 Global Needle-free Hypodermic Syringe Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Needle-free Hypodermic Syringe Sales by Manufacturers (2021-2026)
  3. 3.3 Global Needle-free Hypodermic Syringe Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Needle-free Hypodermic Syringe Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Needle-free Hypodermic Syringe Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Needle-free Hypodermic Syringe Manufacturers, Product Type & Application
  7. 3.7 Global Needle-free Hypodermic Syringe Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Needle-free Hypodermic Syringe Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Needle-free Hypodermic Syringe Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Needle-free Hypodermic Syringe Tier 1, Tier 2, and Tier 3
4 Needle-free Hypodermic Syringe Market by Type
  1. 4.1 Needle-free Hypodermic Syringe Type Introduction
  2. 4.1.1 Electric Needle-Free Injector
  3. 4.1.2 Hydraulic Needle-Free Injector
  4. 4.2 Global Needle-free Hypodermic Syringe Sales by Type
  5. 4.2.1 Global Needle-free Hypodermic Syringe Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Needle-free Hypodermic Syringe Sales by Type (2021-2032)
  7. 4.2.3 Global Needle-free Hypodermic Syringe Sales Market Share by Type (2021-2032)
  8. 4.3 Global Needle-free Hypodermic Syringe Revenue by Type
  9. 4.3.1 Global Needle-free Hypodermic Syringe Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Needle-free Hypodermic Syringe Revenue by Type (2021-2032)
  11. 4.3.3 Global Needle-free Hypodermic Syringe Revenue Market Share by Type (2021-2032)
5 Needle-free Hypodermic Syringe Market by Application
  1. 5.1 Needle-free Hypodermic Syringe Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Specialist Clinic
  4. 5.1.3 Others
  5. 5.2 Global Needle-free Hypodermic Syringe Sales by Application
  6. 5.2.1 Global Needle-free Hypodermic Syringe Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Needle-free Hypodermic Syringe Sales by Application (2021-2032)
  8. 5.2.3 Global Needle-free Hypodermic Syringe Sales Market Share by Application (2021-2032)
  9. 5.3 Global Needle-free Hypodermic Syringe Revenue by Application
  10. 5.3.1 Global Needle-free Hypodermic Syringe Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Needle-free Hypodermic Syringe Revenue by Application (2021-2032)
  12. 5.3.3 Global Needle-free Hypodermic Syringe Revenue Market Share by Application (2021-2032)
6 Global Needle-free Hypodermic Syringe Sales by Region
  1. 6.1 Global Needle-free Hypodermic Syringe Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Needle-free Hypodermic Syringe Sales by Region (2021-2032)
  3. 6.2.1 Global Needle-free Hypodermic Syringe Sales by Region (2021-2026)
  4. 6.2.2 Global Needle-free Hypodermic Syringe Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Needle-free Hypodermic Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Needle-free Hypodermic Syringe Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Needle-free Hypodermic Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Needle-free Hypodermic Syringe Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Needle-free Hypodermic Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Needle-free Hypodermic Syringe Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Needle-free Hypodermic Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Needle-free Hypodermic Syringe Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Needle-free Hypodermic Syringe Revenue by Region
  1. 7.1 Global Needle-free Hypodermic Syringe Revenue by Region
  2. 7.1.1 Global Needle-free Hypodermic Syringe Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Needle-free Hypodermic Syringe Revenue by Region (2021-2026)
  4. 7.1.3 Global Needle-free Hypodermic Syringe Revenue by Region (2027-2032)
  5. 7.1.4 Global Needle-free Hypodermic Syringe Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Needle-free Hypodermic Syringe Revenue (2021-2032)
  8. 7.2.2 North America Needle-free Hypodermic Syringe Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Needle-free Hypodermic Syringe Revenue (2021-2032)
  11. 7.3.2 Europe Needle-free Hypodermic Syringe Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Needle-free Hypodermic Syringe Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Needle-free Hypodermic Syringe Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Needle-free Hypodermic Syringe Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Needle-free Hypodermic Syringe Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Needle-free Hypodermic Syringe Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Aptar Pharma
  8. 8.2.1 Aptar Pharma Company Information
  9. 8.2.2 Aptar Pharma Business Overview
  10. 8.2.3 Aptar Pharma Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aptar Pharma Needle-free Hypodermic Syringe Product Portfolio
  12. 8.2.5 Aptar Pharma Recent Developments
  13. 8.3 Veloxis Pharmaceuticals
  14. 8.3.1 Veloxis Pharmaceuticals Company Information
  15. 8.3.2 Veloxis Pharmaceuticals Business Overview
  16. 8.3.3 Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Product Portfolio
  18. 8.3.5 Veloxis Pharmaceuticals Recent Developments
  19. 8.4 SHL Medical
  20. 8.4.1 SHL Medical Company Information
  21. 8.4.2 SHL Medical Business Overview
  22. 8.4.3 SHL Medical Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SHL Medical Needle-free Hypodermic Syringe Product Portfolio
  24. 8.4.5 SHL Medical Recent Developments
  25. 8.5 Portal Instruments
  26. 8.5.1 Portal Instruments Company Information
  27. 8.5.2 Portal Instruments Business Overview
  28. 8.5.3 Portal Instruments Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Portal Instruments Needle-free Hypodermic Syringe Product Portfolio
  30. 8.5.5 Portal Instruments Recent Developments
  31. 8.6 PharmaJet
  32. 8.6.1 PharmaJet Company Information
  33. 8.6.2 PharmaJet Business Overview
  34. 8.6.3 PharmaJet Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PharmaJet Needle-free Hypodermic Syringe Product Portfolio
  36. 8.6.5 PharmaJet Recent Developments
  37. 8.7 PenJet
  38. 8.7.1 PenJet Company Information
  39. 8.7.2 PenJet Business Overview
  40. 8.7.3 PenJet Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PenJet Needle-free Hypodermic Syringe Product Portfolio
  42. 8.7.5 PenJet Recent Developments
  43. 8.8 Oval Medical Technologies
  44. 8.8.1 Oval Medical Technologies Company Information
  45. 8.8.2 Oval Medical Technologies Business Overview
  46. 8.8.3 Oval Medical Technologies Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Oval Medical Technologies Needle-free Hypodermic Syringe Product Portfolio
  48. 8.8.5 Oval Medical Technologies Recent Developments
  49. 8.9 Lifecare AS
  50. 8.9.1 Lifecare AS Company Information
  51. 8.9.2 Lifecare AS Business Overview
  52. 8.9.3 Lifecare AS Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lifecare AS Needle-free Hypodermic Syringe Product Portfolio
  54. 8.9.5 Lifecare AS Recent Developments
  55. 8.10 Enable Injections
  56. 8.10.1 Enable Injections Company Information
  57. 8.10.2 Enable Injections Business Overview
  58. 8.10.3 Enable Injections Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Enable Injections Needle-free Hypodermic Syringe Product Portfolio
  60. 8.10.5 Enable Injections Recent Developments
  61. 8.11 Crossject
  62. 8.11.1 Crossject Company Information
  63. 8.11.2 Crossject Business Overview
  64. 8.11.3 Crossject Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Crossject Needle-free Hypodermic Syringe Product Portfolio
  66. 8.11.5 Crossject Recent Developments
  67. 8.12 Antares Pharma
  68. 8.12.1 Antares Pharma Company Information
  69. 8.12.2 Antares Pharma Business Overview
  70. 8.12.3 Antares Pharma Needle-free Hypodermic Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Antares Pharma Needle-free Hypodermic Syringe Product Portfolio
  72. 8.12.5 Antares Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Needle-free Hypodermic Syringe Value Chain Analysis
  2. 9.1.1 Needle-free Hypodermic Syringe Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Needle-free Hypodermic Syringe Production Mode & Process
  6. 9.2 Needle-free Hypodermic Syringe Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Needle-free Hypodermic Syringe Distributors
  9. 9.2.3 Needle-free Hypodermic Syringe Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst